Glenmark Chlorzoxazone Tablets 750mg Recall: CGMP Deviations

Take action

Contact the company & request your remedy

Recalling firmGlenmark Pharmaceuticals Inc., USA750 Corporate Dr · Mahwah, NJ 07430-2009

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Glenmark Pharmaceuticals is recalling 750mg chlorzoxazone tablets (NDC 68462-725-01) because of manufacturing quality control issues. This recall affects prescription-only tablets with specific expiration dates and batch numbers.

Why it’s dangerous

CGMP deviations refer to manufacturing quality control issues that could affect product safety. These deviations may lead to inconsistent drug quality or potency, but the exact risk is not specified in the recall notice.

Who’s affected

Prescription holders of chlorzoxazone tablets with the NDC 68462-725-01 and specific batch numbers/expiry dates. Patients using these tablets for muscle spasms may be at risk.

How to tell if you have this one

Check for the NDC code 68462-725-01 on the product label. Look for batch numbers 29200023, 29200025, 29200036, 29200056, or 29200070 with expiration dates from March 31, 2022 through November 30, 2022.

Brand
Glenmark
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Details
Verify the NDC code 68462-725-01 and batch numbers listed in the recall notice.

✎ GovInfoNow

Questions people ask

What is the recall for?

Glenmark Pharmaceuticals is recalling 750mg chlorzoxazone tablets (NDC 68462-725-01) due to CGMP deviations in manufacturing.

Which batches are affected?

Batches 29200023, 29200025, 29200036, 29200056, and 29200070 with expiration dates from March 31, 2022 through November 30, 2022.

Do I need to stop using these tablets?

The recall notice does not specify a stop-use instruction, so you do not need to stop using them immediately.

Take action

Contact Glenmark

We’ve drafted a message you can send Glenmark to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0824-2021 — Glenmark Glenmark

Hello,

I own a Glenmark that is covered by recall D-0824-2021 from Glenmark.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0824-2021 (August 27, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0824-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Glenmark Pharmaceuticals Inc., USA recalls Chlorzoxazone Tablets USP 750 mg 100 Tablets Rx Only NDC 68462-725-01 Manufactured by: Glenmark Pharmaceuticals Inc.,

Recall notice